Preventive medication use among persons with limited life expectancy

Abstract Persons with limited life expectancy (LLE) – less than 1 year – are significant consumers of health care, are at increased risk of polypharmacy and adverse drug events, and have dynamic health statuses. Therefore, medication use among this population must be appropriate and regularly evaluated. The objective of this review is to assess the current state of knowledge and clinical practice presented in the literature regarding preventive medication use among persons with LLE. We searched Medline, Embase, and CINAHL using Medical Subject Headings. Broad searches were first conducted using the terms ‘terminal care or therapy’ or ‘advanced disease’ and ‘polypharmacy’ or ‘inappropriate medication’ or ‘preventive medicine’, followed by more specific searches using the terms ‘statins’ or ‘anti-hypertensives’ or ‘bisphosphonates’ or ‘laxatives’ and ‘terminal care’. Frameworks to assess appropriate versus inappropriate medications for persons with LLE, and the prevalence of potentially inappropriate medication use among this population, are presented. A considerable proportion of individuals with a known terminal condition continue to take chronic disease preventive medications until death despite questionable benefit. The addition of palliative preventive medications is advised. There is an indication that as death approaches the shift from a curative to palliative goal of care translates into a shift in medication use. This literature review is a first step towards improving medication use and decreasing polypharmacy in persons at the end of life. There is a need to develop consensus criteria to assess appropriate versus inappropriate medication use, specifically for individuals at the end of life.

• Publication year

  2011

• Venue

  Progress in Palliative Care

• Publication date

  2011-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1179/174329111X576698PMID 21731193PMCID 3118532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of unnecessary medications by patients with advanced cancer: cross-sectional survey

  2011cited by this paper
• Bone metastases from advanced cancers: clinical implications and treatment options.

  2009cited by this paper
• First-line drugs for hypertension.

  2009cited by this paper
• Impact of a geriatric nursing home palliative care service on unnecessary medication prescribing.

  2009cited by this paper
• Futile medication use in terminally ill cancer patients

  2009cited by this paper
• STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation.

  2008cited by this paper
• The management of constipation in palliative care: clinical practice recommendations

  2008cited by this paper
• Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use

  2008cited by this paper
• Potential drug interactions in cancer patients receiving supportive care exclusively.

  2008cited by this paper
• Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria.

  2008cited by this paper
• Medication use in nursing home residents with advanced dementia

  2008cited by this paper
• Inappropriate prescribing in geriatric patients

  2008cited by this paper
• A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International

  2008cited by this paper
• Statins in the Last Six Months of Life: A Recognizable, Life-Limiting Condition Does Not Decrease their Use

  2008cited by this paper
• Potentially Inappropriate Medication Use by Medicaid+Choice Beneficiaries in the Last Year of Life

  2007cited by this paper
• Authorship Decision Making: An Empirical Investigation

  2007cited by this paper
• Prescribing in Palliative Care as Death Approaches

  2007cited by this paper
• Medication inappropriateness for older adults receiving hospice care: a pilot survey.

  2007cited by this paper
• Frameworks for approaching prescribing at the end of life.

  2006cited by this paper
• Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials

  2006cited by this paper
• Cardiogenic Shock Complicating Acute Myocardial Infarction in the United States, 1979 - 2003: P85

  2006cited by this paper
• Physician Practice in the Discontinuation of Statins among Patients with Advanced Lung Cancer

  2006cited by this paper
• Reconsidering medication appropriateness for patients late in life.

  2006cited by this paper
• Management of common opioid-induced adverse effects.

  2006cited by this paper
• Potentially inappropriate medication use among elderly home care patients in Europe.

  2005cited by this paper
• Discontinuing Cardiovascular Medications at the End of Life: Lipid-Lowering Agents

  2005cited by this paper
• Constipation management in palliative care: a survey of practices in the United kingdom.

  2005cited by this paper
• The Association of Inappropriate Drug Use with Hospitalisation and Mortality

  2005cited by this paper
• Development of Guidelines for Palliative Care Pharmacotherapy

  2005cited by this paper
• Managing comorbidities in patients at the end of life

  2004cited by this paper
• Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".

  2003cited by this paper
• Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

  2003cited by this paper
• Risk for myopathy with statin therapy in high-risk patients.

  2003cited by this paper
• Polypharmacy in palliative care: can it be reduced?

  2002cited by this paper
• Laxative prescribing in relation to opioid use and the influence of pharmacy‐based intervention

  2002cited by this paper
• Futile and inappropriate prescribing: an assessment of the issue in a series of patients admitted to a specialist palliative care unit

  2001cited by this paper
• New insights into the pharmacodynamic and pharmacokinetic properties of statins.

  1999cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Pharmacologic treatment of cancer pain.

  1996cited by this paper
• A method for assessing drug therapy appropriateness.

  1992cited by this paper

• Balancing palliative care needs and medication appropriateness: Initiation and reinitiation of medications at the end of life.

  2025cites this paper
• Hepatitis C—Everything a Primary Care Physician Needs to Know About Diagnosis, Management, and Follow-Up

  2025cites this paper
• The Healthcare Professionals Attitudes Towards Deprescribing (HATD) tool in older persons with multiple long-term chronic conditions and those on palliative care: A mixed methods study.

  2025cites this paper
• Impact of the deprescribing timing on medicines optimisation in older cancer patients receiving hospice care at the end of life: a comparative cohort study

  2025cites this paper
• The impact of palliative care consults on medicines optimisation for patients with cancer referred to hospice care at the end of life: a retrospective cohort study

  2025cites this paper
• Pharmacological approach for pain management in palliative care outpatient department of a South Goa district hospital

  2025cites this paper
• Barriers and enablers of elderly care specialists towards deprescribing practices in the nursing homes: a focus group study

  2025cites this paper
• Resuscitation and survival time in terminal cancer patients at the end of life: A retrospective observational study in a Chinese hospital

  2025cites this paper
• Patterns of medication use following breast cancer diagnosis: an Australian population-based study

  2025cites this paper
• Appropriate use of medication among home care adult cancer patients at end of life: a retrospective observational study

  2024cites this paper
• Polypharmacy and potentially inappropriate medicine use in older adults with cancer: a multicenter cross-sectional study in Northwest Ethiopia oncologic centers

  2024cites this paper
• Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study

  2024cites this paper
• When and in Whom to Initiate HCV Therapy

  2023cites this paper
• The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study

  2023cites this paper
• Deprescription in Palliative Care

  2023influential citation
• Use of preventive medication and supplements in general practice in patients in their last year of life: a Retrospective cohort study

  2023cites this paper
• When and in Whom to Initiate HCV Therapy

  2023cites this paper
• When and in Whom to Initiate HCV Therapy

  2023cites this paper
• Prescribing and deprescribing in older people with life-limiting illnesses receiving hospice care at the end of life: A longitudinal, retrospective cohort study

  2023cites this paper
• When and in Whom to Initiate HCV Therapy

  2023cites this paper
• Assessment of the appropriateness of cardiovascular preventive medication in older people: using the RAND/UCLA Appropriateness Method

  2022cites this paper
• When and in Whom to Initiate HCV Therapy

  2022cites this paper
• Prescription of Potentially Inappropriate Medication Use in Older Cancer Outpatients With Multimorbidity: Concordance Among the Chinese, AGS/Beers, and STOPP Criteria

  2022cites this paper
• Prevalence of polypharmacy and potentially inappropriate medication use in older lung cancer patients: A systematic review and meta-analysis

  2022cites this paper
• Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy.

  2022cites this paper
• Prescribing at 95 years of age: cross-sectional findings from the Newcastle 85+ study

  2022cites this paper
• Is polypharmacy associated with mortality in the very old: Findings from the Newcastle 85+ Study

  2022cites this paper
• The prevalence and factors associated with potentially inappropriate medication use in Chinese older outpatients with cancer with multimorbidity.

  2022cites this paper
• Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional Study

  2022cites this paper
• Involving older people in decisions about deprescribing in end of life care.

  2022cites this paper
• When and in Whom to Initiate HCV Therapy

  2022cites this paper
• When and in Whom to Initiate HCV Therapy

  2022cites this paper
• Evaluation of Direct-acting Antiviral Agents and Clinical Responses in Chronic Hepatitis C Patients

  2022cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• Polypharmacy difference between older people with and without diabetes: evidence from the English Longitudinal Study of Ageing.

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• Use of preventive drugs during the last year of life in older adults with cancer or chronic progressive diseases

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• When and in Whom to Initiate HCV Therapy

  2021cites this paper
• Nonprescription Medication Use in Hospice Patients

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• Outcomes of deprescribing interventions in older patients with life‐limiting illness and limited life expectancy: A systematic review

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• Pharmacology of Aging and Cancer

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review

  2020cites this paper
• Actuarial applications of survival analysis in healthcare

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study

  2020cites this paper
• Polypharmacy, Medication Possession, and Deprescribing of Potentially Non-Beneficial Drugs in Hospice Patients

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• Inappropriate medications among end-of-life patients living at home: an Italian observational study

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2020cites this paper
• When and in Whom to Initiate HCV Therapy

  2019cites this paper
• Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines

  2019cites this paper
• When and in Whom to Initiate HCV Therapy

  2019cites this paper
• Too much, too late? Drug prescribing for older people near the end of life

  2019cites this paper
• Deprescribing of medications at the end of life : data of older adults living at home or in a nursing home, and patients with advanced cancer receiving palliative care

  2019cites this paper
• When and in Whom to Initiate HCV Therapy

  2019cites this paper
• Polypharmacy patterns in the last year of life in patients with dementia

  2019cites this paper